title: Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes.
authors.forename: Rhonda
authors.initials: R
authors.lastname: Cooper-DeHoff
authors.forename: Carl J
authors.initials: CJ
authors.lastname: Pepine
mesh_terms: D000083:Acetanilides; D000787:Angina Pectoris / Q000188:drug therapy* / Q000503:physiopathology; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000503:physiopathology; D017079:Exercise Tolerance; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D000069458:Ranolazine
chemical_list: D000083:Acetanilides; D002316:Cardiotonic Agents; D010879:Piperazines; D000069458:Ranolazine